Cargando…
SPARC inhibits breast cancer bone metastasis and may be a clinical therapeutic target
Breast cancer is one of the most common types of cancer in females worldwide, and metastasis to bone is an important characteristic of malignancy. The present study aimed to investigate the molecular mechanism of breast cancer to bone metastasis of secreted protein acidic and rich in cysteine (SPARC...
Autores principales: | Ma, Jingjing, Gao, Sheng, Xie, Xiju, Sun, Erhu, Zhang, Min, Zhou, Qian, Lu, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661402/ https://www.ncbi.nlm.nih.gov/pubmed/29113221 http://dx.doi.org/10.3892/ol.2017.6925 |
Ejemplares similares
-
Targeting SPARC by lentivirus-mediated RNA interference inhibits cervical cancer cell growth and metastasis
por: Chen, Jie, et al.
Publicado: (2012) -
SPARC: A Potential Prognostic and Therapeutic Target in Pancreatic Cancer
por: Vaz, Juan, et al.
Publicado: (2015) -
Roles of SPARC in urothelial carcinogenesis, progression and metastasis
por: Said, Neveen
Publicado: (2016) -
miR-211 inhibits proliferation, invasion and migration of cervical cancer via targeting SPARC
por: Qu, Xuqin, et al.
Publicado: (2018) -
MiR-29c-3p inhibits epithelial-mesenchymal transition to inhibit the proliferation, invasion and metastasis of cervical cancer cells by targeting SPARC
por: Zou, Ting, et al.
Publicado: (2021)